Marc Kovalchik
Psychiatric/Mental Health, Adult · Wilkes Barre, PANPI 1871925842
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,143, 2.3 times the $489 reported in 2021. Among psychiatric/mental health, adult clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$662
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$583
- Otsuka America Pharmaceutical, Inc.$562
- Lundbeck LLC$545
- Takeda Pharmaceuticals U.S.A., Inc.$512
- Neurocrine Biosciences, Inc.$485
- plus $1K from 10 others
What the payments were for
- Food & beverage$4,37999%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $662 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $583 |
| Otsuka America Pharmaceutical, Inc. | 34 | $562 |
| Lundbeck LLC | 41 | $545 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $512 |
| Neurocrine Biosciences, Inc. | 29 | $485 |
| Bausch Health US, LLC | 18 | $364 |
| Vanda Pharmaceuticals Inc. | 11 | $174 |
| Alkermes, Inc. | 11 | $170 |
| Ironshore Pharmaceuticals Inc. | 5 | $72 |
| Collegium Pharmaceutical, Inc. | 4 | $64 |
| Jazz Pharmaceuticals Inc. | 3 | $58 |
| Johnson & Johnson | 2 | $52 |
| Corium, LLC | 3 | $50 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Noven Therapeutics, LLC | 1 | $24 |
How this compares
$4,425 in reported general payments places this provider in the 95th percentile of 20 psychiatric/mental health, adult providers in Pennsylvania.
See all psychiatric/mental health, adult providers in Pennsylvania →
Other psychiatric/mental health, adult in Wilkes Barre
- Steven WeissDoylestown$2K
- Barbara BuxtonWest Wyoming$2K
- Gabriela DominguezScranton$2K
- Sam SimonPhiladelphia$2K
- Elizabeth DowlingPlymouth Meeting$1K
- Patricia HannonWest Wyoming$483
- Susan SacksPlymouth Meeting$354
- Patricia AllenNorth Wales$295
- Doris VallonePhiladelphia$232
- Barbara FieldPhiladelphia$118
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.